Evidence map›Paper›PMID 38009291›Full record

ArticleAdvanced healthcare materials2024

SDF-1 Bound Heparin Nanoparticles Recruit Progenitor Cells for Their Differentiation and Promotion of Angiogenesis after Stroke.

Katrina L Wilson, Neica I Joseph, Lauren A Onweller, Alexa R Anderson, Nicole J Darling, Jennifer David-Bercholz, Tatiana Segura

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Katrina L WilsonDepartment of Biomedical Engineering, Duke University, Durham, NC, 27708-0281, USA.ORCID 0000-0003-1389-1327
Neica I JosephDepartment of Biomedical Engineering, Duke University, Durham, NC, 27708-0281, USA.
Lauren A OnwellerDepartment of Biomedical Engineering, Duke University, Durham, NC, 27708-0281, USA.ORCID 0009-0004-0865-4495
Alexa R AndersonDepartment of Biomedical Engineering, Duke University, Durham, NC, 27708-0281, USA.ORCID 0000-0002-8566-4310
Nicole J DarlingDepartment of Chemical and Biomolecular Engineering, University of California Los Angeles, Los Angeles, CA, 90095, USA.
Jennifer David-BercholzDepartment of Anesthesiology, Duke University, Durham, NC, 27708-0281, USA.
Tatiana SeguraDepartment of Biomedical Engineering, Duke University, Durham, NC, 27708-0281, USA.ORCID 0000-0003-1569-8686

Funding

VEGF Ligand Presentation and Therapeutic AngiogenesisR01NS079691 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SEGURA, TATIANA · 2012 to 2024
$4.0M
Biomaterials to promote synapse formation after strokeR01NS112940 · NINDS · DUKE UNIVERSITY · PI Tatiana Segura · 2020 to 2026
$3.9M
University Training Program in Biomolecular and Tissue EngineeringT32GM144291 · NIGMS · DUKE UNIVERSITY · PI Charles A. Gersbach, Tatiana Segura · 2022 to 2026
$2.6M
Engineering Injectable Microporous Hydrogels for Brain RepairR01NS094599 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SEGURA, TATIANA · 2016 to 2019
$1.5M
NIGMS NIH HHS T32 GM144291NIH HHSNINDS NIH HHS R01 NS079691NINDS NIH HHS R01NS079691NINDS NIH HHS R01 NS094599NINDS NIH HHS R01NS094599NINDS NIH HHS R01 NS112940
6 · The paper itself

Abstract

Angiogenesis after stroke is correlated with enhanced tissue repair and functional outcomes. The existing body of research in biomaterials for stroke focuses on hydrogels for the delivery of stem cells, growth factors, or small molecules or drugs. Despite the ability of hydrogels to enhance all these delivery methods, no material has significantly regrown vasculature within the translatable timeline of days to weeks after stroke. Here, two novel biomaterial formulations of granular hydrogels are developed for tissue regeneration after stroke: highly porous microgels (i.e., Cryo microgels) and microgels bound with heparin-norbornene nanoparticles with covalently bound SDF-1α. The combination of these materials results in perfused vessels throughout the stroke core in only 10 days, in addition to increased neural progenitor cell recruitment, maintenance, and increased neuronal differentiation.

Indexed as

Cell DifferentiationChemokine CXCL12HeparinNanoparticlesNeovascularization, PhysiologicStrokeAngiogenesisAnimalsHydrogelsMaleMiceNeural Stem CellsStem CellsChemokine CXCL12HeparinHydrogelscryogelshydrogelmicrogel/microparticlemicroporous annealed particleneural stem cellsstrokestromal cell‐derived factor 1

Identifiers

PMID38009291
PMCPMC11128481

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.